Get started
Author

Barbara Montico

Observed names: B. Montico, Montico, Barbara
ORCID: 0000-0001-6783-2969
Observed ORCID: 0000-0001-6783-2969
OpenAlex ID: A5086762891
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
2021 · Daniel J. Klionsky, Amal Kamal Abdel-Aziz, et al. · Autophagy · 2,608
PDF
Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development
2018 · Barbara Montico, Annunziata Nigro, et al. · International Journal of Molecular Sciences · 128
PDF
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
2021 · Klionsky, Daniel J, Abdel-Aziz, Amal Kamal, et al. · Research at the University of Copenhagen (University of Copenhagen) · 104
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC
2020 · Annunziata Nigro, Luca Ricciardi, et al. · Frontiers in Immunology · 70
PDF
Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy
2017 · B. Montico, C. Lapenta, et al. · OncoImmunology · 58
PDF
Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
2019 · Michela Cangemi, Barbara Montico, et al. · Frontiers in Oncology · 41
PDF
Phospholipid scramblase 1: a protein with multiple functions via multiple molecular interactors
2022 · Jessica Dal Col, Marìa Julia Lamberti, et al. · Cell Communication and Signaling · 38
PDF
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies
2016 · Elisabetta Fratta, Barbara Montico, et al. · Oncotarget · 25
PDF
LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer
2022 · Mariateresa Casarotto, Valentina Lupato, et al. · Clinical Epigenetics · 22
PDF
The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma
2021 · Barbara Montico, Giorgio Giurato, et al. · Molecular Oncology · 22
Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma
2016 · Katy Mastorci, Barbara Montico, et al. · Oncotarget · 22
PDF
Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy
2020 · Barbara Montico, Francesca Colizzi, et al. · Cell Death and Disease · 19
PDF
Autophagy in BRAF-mutant cutaneous melanoma: recent advances and therapeutic perspective
2023 · Elisabetta Fratta, Giorgio Giurato, et al. · Cell Death Discovery · 17
PDF
Unraveling the role of hypoxia-inducible factors in cutaneous melanoma: from mechanisms to therapeutic opportunities
2025 · Arianna Bellazzo, Barbara Montico, et al. · Cell Communication and Signaling · 13
PDF
Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma
2025 · Barbara Montico, Giorgio Giurato, et al. · Journal of Experimental & Clinical Cancer Research · 10
PDF
A Novel Dendritic Cell-Based Vaccination Protocol to Stimulate Immunosurveillance of Aggressive Cancers
2018 · Annunziata Nigro, Barbara Montico, et al. · Methods in molecular biology · 10
Integration of miRNA:mRNA Co-Expression Revealed Crucial Mechanisms Modulated in Immunogenic Cancer Cell Death
2022 · María Julia Lamberti, Barbara Montico, et al. · Biomedicines · 9
PDF
Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers
2021 · Giulia Brisotto, Roberto Guerrieri, et al. · Methods in molecular biology · 6
Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors
2024 · Elena Muraro, Barbara Montico, et al. · Frontiers in Immunology · 5
Phospholipid scramblase 1 is involved in immunogenic cell death and contributes to dendritic cell–based vaccine efficiency to elicit antitumor immune response in vitro
2023 · Barbara Montico, Annunziata Nigro, et al. · Cytotherapy · 3
Abstract B06: Loss of SPRY1 expression in BRAF-mutant cutaneous melanoma inhibits cell proliferation and improves response to targeted therapy
2020 · Barbara Montico, Giorgio Giurato, et al. · Cancer Research · 2
Non-coding RNA profiling in BRAFV600E-mutant cutaneous melanoma before and after Spry1 depletion
2025 · Jessica Lamberti, Domenico Memoli, et al. · Scientific Data · 1
PDF
Abstract 202: Spry1 targeting enhances E-cadherin expression in cutaneous melanoma
2024 · Barbara Montico, Giorgio Giurato, et al. · Cancer Research · 1
Correction: Suppression of Spry1 reduces HIF1α‑dependent glycolysis and impairs angiogenesis in BRAF‑mutant cutaneous melanoma
2026 · Barbara Montico, Giorgio Giurato, et al. · Journal of Experimental & Clinical Cancer Research
PDF
281 (PB269): Emerging role of HOXB9 transcription factor in cutaneous melanoma
2024 · B. Montico, A. Bellazzo, et al. · European Journal of Cancer
Works count: 62
Citation count: 3,230
H-index: 13
I10-index: 16
Year
Topic
Type